Beranda › Kanker Paru › Florida › Clearwater
Uji klinis Kanker Paru di Clearwater, FL
4 studi untuk Kanker Paru mencari peserta di lokasi sekitar Clearwater (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Morton Plant Hospital, Clearwater
- Mease Countryside Hospital, Safety Harbor · 7 mi jauhnya
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Morton Plant Hospital, Clearwater
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Florida Cancer Specialists, Clearwater
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Morton Plant Hospital, Clearwater
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Clearwater
- Penyakit Kardiovaskular9 studi
- Lupus8 studi
- Obesitas7 studi
- Kanker Payudara6 studi
- Gagal Jantung6 studi
- Artritis Psoriatik5 studi
- Kelebihan Berat Badan5 studi
- Kanker Paru Non-Sel Kecil5 studi
- Penyakit Arteri Koroner5 studi
- Fibrilasi Atrium5 studi
- Diabetes Tipe 24 studi
- Kolesterol4 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.